Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations
Author
Abstract
Suggested Citation
DOI: 10.1016/j.healthpol.2016.09.013
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Drummond, Michael F. & Sculpher, Mark J. & Torrance, George W. & O'Brien, Bernie J. & Stoddart, Greg L., 2005. "Methods for the Economic Evaluation of Health Care Programmes," OUP Catalogue, Oxford University Press, edition 3, number 9780198529453.
- Judith Bosmans & Oscar Brook & Hein Hout & Martine Bruijne & Hugo Nieuwenhuyse & Lex Bouter & Wim Stalman & Maurits Tulder, 2007. "Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants," PharmacoEconomics, Springer, vol. 25(1), pages 25-37, January.
- Dyfrig Hughes & Joanna Charles & Dalia Dawoud & Rhiannon Tudor Edwards & Emily Holmes & Carys Jones & Paul Parham & Catrin Plumpton & Colin Ridyard & Huw Lloyd-Williams & Eifiona Wood & Seow Tien Yeo, 2016. "Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches," PharmacoEconomics, Springer, vol. 34(5), pages 447-461, May.
- Rachel Elliott & Koen Putman & Matthew Franklin & Lieven Annemans & Nick Verhaeghe & Martin Eden & Jasdeep Hayre & Sarah Rodgers & Aziz Sheikh & Anthony Avery, 2014. "Cost Effectiveness of a Pharmacist-Led Information Technology Intervention for Reducing Rates of Clinically Important Errors in Medicines Management in General Practices (PINCER)," PharmacoEconomics, Springer, vol. 32(6), pages 573-590, June.
- Mossialos, Elias & Courtin, Emilie & Naci, Huseyin & Benrimoj, Shalom & Bouvy, Marcel & Farris, Karen & Noyce, Peter & Sketris, Ingrid, 2015. "From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease management," Health Policy, Elsevier, vol. 119(5), pages 628-639.
- Mossialos, Elias & Naci, Huseyin & Courtin, Emilie, 2013. "Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence?," Health Policy, Elsevier, vol. 111(2), pages 135-148.
- Francisco Jódar-Sánchez & Amaia Malet-Larrea & José Martín & Leticia García-Mochón & M. López del Amo & Fernando Martínez-Martínez & Miguel Gastelurrutia-Garralda & Victoria García-Cárdenas & Daniel S, 2015. "Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program," PharmacoEconomics, Springer, vol. 33(6), pages 599-610, June.
- Clémence Perraudin & Marc Le Vaillant & Nathalie Pelletier-Fleury, 2013. "Cost-Effectiveness of a Community Pharmacist-Led Sleep Apnea Screening Program – A Markov Model," PLOS ONE, Public Library of Science, vol. 8(6), pages 1-9, June.
- Maria Rubio-Valera & Judith Bosmans & Ana Fernández & Maite Peñarrubia-María & Marian March & Pere Travé & Juan A Bellón & Antoni Serrano-Blanco, 2013. "Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study)," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-10, August.
- Edmunds, June & Calnan, Michael W., 2001. "The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practioners in the United Kingdom," Social Science & Medicine, Elsevier, vol. 53(7), pages 943-955, October.
- Kim Olsen & Lone Bilde & Henrik Juhl & Niels Kjaer & Holger Mosbech & Torben Evald & Mette Rasmussen & Helle Hiladakis, 2006. "Cost-effectiveness of the Danish smoking cessation interventions," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(4), pages 255-264, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Rachel Elliott & Koen Putman & James Davies & Lieven Annemans, 2014. "A Review of the Methodological Challenges in Assessing the Cost Effectiveness of Pharmacist Interventions," PharmacoEconomics, Springer, vol. 32(12), pages 1185-1199, December.
- Patton, Sarah J. & Miller, Fiona A. & Abrahamyan, Lusine & Rac, Valeria E., 2018. "Expanding the clinical role of community pharmacy: A qualitative ethnographic study of medication reviews in Ontario, Canada," Health Policy, Elsevier, vol. 122(3), pages 256-262.
- de Bruin, Simone R. & Heijink, Richard & Lemmens, Lidwien C. & Struijs, Jeroen N. & Baan, Caroline A., 2011. "Impact of disease management programs on healthcare expenditures for patients with diabetes, depression, heart failure or chronic obstructive pulmonary disease: A systematic review of the literature," Health Policy, Elsevier, vol. 101(2), pages 105-121, July.
- Anderson, Michael & O'Neill, Ciaran & Macleod Clark, Jill & Street, Andrew & Woods, Michael & Johnston-Webber, Charlotte & Charlesworth, Anita & Whyte, Moira & Foster, Margaret & Majeed, Azeem & Pitch, 2021. "Securing a sustainable and fit-for-purpose UK health and care workforce," LSE Research Online Documents on Economics 110809, London School of Economics and Political Science, LSE Library.
- Sabrine Elkhodr & Maya Saba & Claire O’Reilly & Bandana Saini, 2018. "The role of community pharmacists in the identification and ongoing management of women at risk for perinatal depression: A qualitative study," International Journal of Social Psychiatry, , vol. 64(1), pages 37-48, February.
- Saha, Sanjib & Gerdtham, Ulf-G. & Toresson, Håkan & Minthon, Lennart & Jarl, Johan, 2018. "Economic Evaluation of Interventions for Screening of Dementia," Working Papers 2018:20, Lund University, Department of Economics.
- Mark Oppe & Daniela Ortín-Sulbarán & Carlos Vila Silván & Anabel Estévez-Carrillo & Juan M. Ramos-Goñi, 2021. "Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 711-721, July.
- Ties Hoomans & Johan Severens & Nicole Roer & Gepke Delwel, 2012. "Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands," PharmacoEconomics, Springer, vol. 30(3), pages 219-227, March.
- Khan, Md. Tajuddin & Kishore, Avinash & Joshi, Pramod Kumar, 2016.
"Gender dimensions on farmers’ preferences for direct-seeded rice with drum seeder in India:,"
IFPRI discussion papers
1550, International Food Policy Research Institute (IFPRI).
- Md. Tajuddin Khan & Avinash Kishore & P.K. Joshi, 2016. "Gender Dimensions on Farmers’ Preferences for Direct-Seeded Rice with Drum Seeder in India," Working Papers id:11274, eSocialSciences.
- Jose L Burgos & Thomas L Patterson & Joshua S Graff-Zivin & James G Kahn & M Gudelia Rangel & M Remedios Lozada & Hugo Staines & Steffanie A Strathdee, 2016. "Cost-Effectiveness of Combined Sexual and Injection Risk Reduction Interventions among Female Sex Workers Who Inject Drugs in Two Very Distinct Mexican Border Cities," PLOS ONE, Public Library of Science, vol. 11(2), pages 1-15, February.
- Najmiatul Fitria & Antoinette D. I. Asselt & Maarten J. Postma, 2019. "Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 407-417, April.
- Thomas Grochtdreis & Hans-Helmut König & Alexander Dobruschkin & Gunhild von Amsberg & Judith Dams, 2018. "Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review," PLOS ONE, Public Library of Science, vol. 13(12), pages 1-25, December.
- Kim Jeong & John Cairns, 2013. "Review of economic evidence in the prevention and early detection of colorectal cancer," Health Economics Review, Springer, vol. 3(1), pages 1-10, December.
- Fleurbaey, Marc & Zuber, Stéphane, 2017.
"Fair management of social risk,"
Journal of Economic Theory, Elsevier, vol. 169(C), pages 666-706.
- Marc Fleurbaey & Stéphane Zuber, 2014. "Fair management of social risk," Documents de travail du Centre d'Economie de la Sorbonne 14016, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne.
- Stéphane Zuber & Marc Fleurbaey, 2017. "Fair management of social risk," PSE-Ecole d'économie de Paris (Postprint) halshs-01503848, HAL.
- Marc Fleurbaey & Stéphane Zuber, 2016. "Fair management of social risk," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-00973480, HAL.
- Stéphane Zuber & Marc Fleurbaey, 2017. "Fair management of social risk," Post-Print halshs-01503848, HAL.
- Stéphane Zuber & Marc Fleurbaey, 2017. "Fair management of social risk," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-01503848, HAL.
- Marc Fleurbaey & Stephane Zuber Zuber, 2016. "Fair Management of Social Risk," Working Papers 059_2014, Princeton University, Department of Economics, Econometric Research Program..
- Marc Fleurbaey & Stéphane Zuber, 2014. "Fair management of social risk," Documents de travail du Centre d'Economie de la Sorbonne 14016r, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne, revised Sep 2015.
- Marc Fleurbaey & Stéphane Zuber, 2016. "Fair management of social risk," Post-Print halshs-00973480, HAL.
- Marc Fleurbaey & Stéphane Zuber, 2014. "Fair management of social risk," Documents de travail du Centre d'Economie de la Sorbonne 14016rr, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne, revised Dec 2016.
- Boone, Jan, 2015.
"Basic versus supplementary health insurance: Moral hazard and adverse selection,"
Journal of Public Economics, Elsevier, vol. 128(C), pages 50-58.
- Boone, Jan, 2014. "Basic versus supplementary health insurance: moral hazard and adverse selection," CEPR Discussion Papers 10199, C.E.P.R. Discussion Papers.
- Boone, J., 2014. "Basic Versus Supplementary Health Insurance : Moral Hazard and Adverse Selection," Discussion Paper 2014-059, Tilburg University, Center for Economic Research.
- Boone, J., 2014. "Basic Versus Supplementary Health Insurance : Moral Hazard and Adverse Selection," Discussion Paper 2014-034, Tilburg University, Tilburg Law and Economic Center.
- Eleanor Heather & Katherine Payne & Mark Harrison & Deborah Symmons, 2014. "Including Adverse Drug Events in Economic Evaluations of Anti-Tumour Necrosis Factor-α Drugs for Adult Rheumatoid Arthritis: A Systematic Review of Economic Decision Analytic Models," PharmacoEconomics, Springer, vol. 32(2), pages 109-134, February.
- Manuel Gomes & Robert Aldridge & Peter Wylie & James Bell & Owen Epstein, 2013. "Cost-Effectiveness Analysis of 3-D Computerized Tomography Colonography Versus Optical Colonoscopy for Imaging Symptomatic Gastroenterology Patients," Applied Health Economics and Health Policy, Springer, vol. 11(2), pages 107-117, April.
- Hareth Al-Janabi & Job van Exel & Werner Brouwer & Joanna Coast, 2016. "A Framework for Including Family Health Spillovers in Economic Evaluation," Medical Decision Making, , vol. 36(2), pages 176-186, February.
- Fan Yang & Colin Angus & Ana Duarte & Duncan Gillespie & Mark Sculpher & Simon Walker & Susan Griffin, 2021. "Comparing smoking cessation to screening and brief intervention for alcohol in distributional cost effectiveness analysis to explore the sensitivity of results to socioeconomic inequalities characteri," Working Papers 184cherp, Centre for Health Economics, University of York.
- Simon Eckermann & Tim Coelli, 2008. "Including quality attributes in a model of health care efficiency: A net benefit approach," CEPA Working Papers Series WP032008, School of Economics, University of Queensland, Australia.
More about this item
Keywords
Community pharmacist; Professional services; Economic evaluation; Cost-effectiveness analysis; Systematic review;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:120:y:2016:i:12:p:1350-1362. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.